Dr. Hakan Kaya
Claim this profileGSK Investigational Site
Studies Relapse
Studies Multiple Myeloma
1 reported clinical trial
1 drug studied
More about Hakan Kaya
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Hakan Kaya has experience with
- Belantamab Mafodotin
Breakdown of trials Hakan Kaya has run
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hakan Kaya specialize in?
Hakan Kaya focuses on Relapse and Multiple Myeloma. In particular, much of their work with Relapse has involved treating patients, or patients who are undergoing treatment.
Is Hakan Kaya currently recruiting for clinical trials?
No, Hakan Kaya is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Hakan Kaya has studied deeply?
Yes, Hakan Kaya has studied treatments such as Belantamab mafodotin.
What is the best way to schedule an appointment with Hakan Kaya?
Apply for one of the trials that Hakan Kaya is conducting.
What is the office address of Hakan Kaya?
The office of Hakan Kaya is located at: GSK Investigational Site, Spokane, Washington 99218 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.